FitLife Brands (FTLF) Q3 2026 Earnings Call Transcript

The Motley Fool · 1d ago
Logo of jester cap with thought bubble.

Image source: The Motley Fool.

DATE

Mon, Nov. 16, 2026

CALL PARTICIPANTS

  • Chief Executive Officer - Dayton Judd
  • President - Ryan Hansen
  • Chief Financial Officer - Jakob York

TAKEAWAYS

  • Total Revenue -- $25.6 million, an increase of 9% compared to the prior year third quarter, driven by a full quarter of Irwin revenue.
  • Net Income -- $1.6 million, an increase of 71% from $0.9 million in the third quarter of 2025.
  • Diluted EPS -- $0.16, compared to $0.09 in the same period last year.
  • Online Revenue -- $11.8 million, growing 15% year over year to represent 46% of total revenue.
  • Adjusted EBITDA -- $3.3 million, down from $3.8 million in the prior year quarter.
  • Legacy FitLife Revenue -- $12.6 million, which management characterized as stable throughout the current year.
  • Irwin Revenue -- $13.0 million, representing a 91% increase from the partial period reported in the prior year.
  • Amazon Active Subscribers -- approximately 96,500, increasing from 94,000 reported in Aug. 2026.
  • Consolidated Gross Margin -- 37.7%, compared to 37.2% in the third quarter of 2025.
  • Irwin Online Revenue -- $3.6 million, an increase of 5% sequentially and representing 28% of Irwin revenue compared to 5% a year ago.
  • Legacy FitLife Gross Margin -- 41.6%, up from 39.3% in the prior year third quarter.
  • Restructuring Savings -- $1.2 million in expected annual operating expense reductions, with savings beginning in the fourth quarter of 2026.
  • Debt -- $39.3 million at the end of the quarter, including $34.5 million on a term loan and $4.8 million on a revolving line of credit.
  • Working Capital -- $13.1 million, an increase of $3.5 million sequentially due to deliberate commodity inventory builds.
  • Whey Protein Forward Purchases -- $1.4 million in final payments during the quarter to lock in protein prices between $5 per pound to $7.17 per pound.
  • Contribution Margin -- 31.5% of revenue, totaling $8.1 million.
  • GNC Revenue -- approximately $10 million on a trailing 12-month basis, representing roughly 10% of total revenue.
  • Irwin Amazon Run Rate -- exceeded $12 million at the end of the third quarter.
  • Legacy FitLife Online Revenue -- $8.2 million, accounting for 65% of the segment total.
  • Legacy Wholesale Revenue -- declined 34% year over year, primarily due to reduced sales to retail partners like GNC.

Need a quote from a Motley Fool analyst? Email pr@fool.com

RISKS

  • Judd stated, "Our business continues to be challenged by a weak consumer environment and some headwinds such as Amazon algorithms, algorithm changes and softness in the specialty retail and health food channels are outside our control," noting external factors impacting segment performance.
  • Judd noted that for GNC franchise locations, "there's been a double-digit decline in the number of doors," explaining that when stores close, the company loses those associated sales.

SUMMARY

FitLife Brands, Inc. (NASDAQ:FTLF) reported year-over-year revenue growth driven by the integration of the Irwin brand and expansion in digital sales channels. Management completed a restructuring program involving headcount reductions and facility consolidation to lower the company's annual cost structure. The company increased working capital to fund strategic forward purchases of key commodities, aiming to protect margins against rising global costs for protein and fish oil. Performance in the online segment reached record levels for specific brands, offsetting declines in the specialty retail channel and legacy wholesale business. Management indicated that the business has maintained relatively stable revenue and adjusted EBITDA levels over the preceding four quarters.

  • Management transitioned advertising spend for the MRC brands toward direct-to-consumer platforms. CEO Judd stated, "We've shifted the advertising dollars to try and build awareness off Amazon."
  • The company is modifying product packaging for high-volume Irwin SKUs to improve online margins. Judd indicated that the company will utilize plastic bottles for the Amazon channel while maintaining glass for brick-and-mortar retail.
  • The MusclePharm brand achieved record online revenue levels. Judd indicated that "every month for the past couple of few months has been a new all-time high for MusclePharm."
  • Operational efficiencies included a reduction in occupancy costs for the Los Angeles office. Judd stated that the company will "save like 50% on our occupancy in L.A."
  • Strategic forward buying of fish oil was completed to mitigate supply shortages. Judd reported, "With those payments made, we have locked in fixed price fish oil for the majority of our needs over the next 12 months."

INDUSTRY GLOSSARY

  • MRC: The Management Resource Center brand group, which includes labels such as Dr. Tobias.
  • GNC: General Nutrition Centers, a global specialty retailer of health and wellness products.
  • Whey Protein: A high-quality protein derived from dairy, used as a primary ingredient in athletic supplements.
  • FBA: Fulfillment by Amazon, a service where Amazon handles storage, packaging, and shipping for third-party sellers.
  • HFS: Health food stores, a specialty retail channel for natural and nutritional products.
  • 3PL: Third-party logistics, referring to outsourced warehouse and distribution services.
  • GLP-1: A class of medications used for weight management that often requires increased protein intake to maintain muscle mass.

Full Conference Call Transcript

Operator: Greetings. Welcome to the FitLife Brands Q3 Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Dayton Judd. You may begin.

Dayton Judd: Good afternoon. I'd like to welcome everyone to FitLife's Third Quarter 2026 Earnings Call. We appreciate you taking the time to join us this afternoon. Joining me on the call is FitLife's President, Ryan Hansen; and FitLife's CFO, Jakob York. For the third quarter of 2026, total revenue was $25.6 million, an increase of 9% from the third quarter of 2025. Growth came from a full quarter of Irwin, partially offset by a year-over-year revenue decline for Legacy FitLife. Online revenue was $11.8 million, an increase of 15% year-over-year and represented 46% of total revenue. Gross margin was 37.7%, up from 37.2% a year ago.

Excluding the $0.4 million of inventory step-up amortization in the prior year quarter, the gross margin during the third quarter last year was 38.9%. Gross margin improved sequentially from 37.0% in the second quarter. Contribution, which we define as gross profit less advertising and marketing expense, grew 10% to $8.1 million or 31.5% of revenue. Net income was $1.6 million, up 71% from $0.9 million a year ago. Diluted earnings per share was $0.16 compared to $0.09 last year, and basic earnings per share was $0.17 compared to $0.10 last year. Adjusted EBITDA was $3.3 million compared to $3.8 million a year ago.

For the trailing 12 months, the company generated $103.4 million of revenue and $13.7 million of adjusted EBITDA. Although some brands and channels continue to be challenged, others are growing. Sequentially, for each of the past 4 quarters, revenue for the combined business has been relatively stable between $25.3 million and $26.5 million, and adjusted EBITDA has also been consistently between $3.3 million and $3.7 million. During the third quarter, we completed a restructuring initiative to improve efficiency and lower our cost structure. We recorded $0.3 million of restructuring expense, primarily severance, and we expect the initiative to reduce annual operating expense by approximately $1.2 million with savings beginning in the fourth quarter of 2026. Turning to brand level performance.

I'll start with Legacy FitLife, which includes MRC and MusclePharm. Legacy FitLife revenue was $12.6 million, and it has been stable throughout the year, growing 1.5% sequentially in the third quarter of 2026 compared to the second quarter of 2026. Year-over-year, wholesale revenue for Legacy FitLife was down 34%, primarily due to reduced sales to certain retail partners, mainly GNC. However, wholesale revenue for Legacy FitLife has increased sequentially from Q1 to Q2 and from Q2 to Q3, largely offsetting the declines in online revenue driven by MRC. Online revenue for Legacy FitLife was $8.2 million or 65% of total revenue.

Gross margin for Legacy FitLife was 41.6%, up from 39.3% a year ago and similar to the second quarter's 41.7% gross margin. Contribution from Legacy FitLife was $4.2 million or 33.6% of revenue, up from 31.5% during the third quarter of 2025. Sequentially, the Legacy FitLife business has been remarkably stable over the last 3 quarters. Total revenue has ranged between $12.4 million and $12.6 million, with sequential growth in wholesale revenue, largely offsetting the sequential declines in online revenue driven by MRC. Gross margin has ranged between 41.2% and 41.7% and contribution has ranged between $4.2 million and $4.3 million.

The MusclePharm brand is doing well with online revenue during the quarter reaching an all-time high and wholesale revenue reaching its second highest quarter since we have owned the brand. All of this at significantly higher gross margin. Moving on now to Irwin. Irwin generated $13.0 million of revenue, a 91% increase from the partial period last year. Online revenue rose 5% sequentially to $3.6 million and now represents 28% of Irwin's revenue, up from approximately 5% a year ago. Irwin's annual revenue run rate on Amazon exceeded $12 million at the end of the third quarter. Wholesale revenue for Irwin during the quarter was $9.4 million.

Gross margin for Irwin during the quarter was 34.0% and contribution was $3.9 million or 29.6% of revenue. Now I'll provide a few additional high-level comments, and then we can open the call for questions. I know some of you like to track subscriber counts. So as of today, we have approximately 96,500 active Amazon subscribers, up from 94,000 when we held our previous earnings call in August. Our business continues to be challenged by a weak consumer environment and some headwinds such as Amazon algorithms, algorithm changes and softness in the specialty retail and health food channels are outside our control.

With that backdrop, though, we are building a stronger supply chain and new product pipeline as well as a more efficient cost base. On a consolidated basis, online revenue continues to grow with Irwin and MusclePharm delivering all-time highs during the quarter. And we believe that the cost actions we have taken will favorably impact SG&A and cost of goods sold. These cost actions include the $1.2 million expected savings from the restructuring I previously mentioned as well as additional non-headcount-related savings. We ended the quarter with $39.3 million of debt, consisting of $34.5 million on our term loan and $4.8 million on our revolving line of credit.

Our net debt increased slightly from $37.0 million at the end of the second quarter to $38.6 million at the end of the third quarter. Given our general trend of reducing indebtedness each quarter, I want to comment on reasons for the increase. In short, working capital increased $3.5 million sequentially from $9.6 million at the end of the second quarter to $13.1 million at the end of the third quarter. More specifically, inventory increased $1.7 million, receivables increased $1.1 million and prepaids increased $0.7 million, while payables only increased $0.3 million.

A large part of the increase in working capital reflects deliberate decisions we made to lock in commodity pricing through forward purchases of whey protein and fish oil, 2 commodities facing sharp cost increases due to supply shortages. With those payments made, we have locked in fixed price fish oil for the majority of our needs over the next 12 months, and we expect working capital to normalize over time. Over time, we also expect these forward purchases will convert to cash at higher margins than if we had purchased on the spot market. Our weighted average cost of debt is approximately 6.7%, and we intend to continue deploying excess free cash flow toward debt reduction.

So that concludes my opening commentary, and we can now go ahead and open it up for questions.

Operator: [Operator Instructions] The first question comes from Ryan Meyers with Lake Street.

Luke Fingerson: Luke Fingerson on for Ryan Meyers. You expect $1.2 million of annual OpEx savings beginning in Q4. Should we expect this $300,000 benefit immediately? Or does that ramp over a couple of quarters?

Dayton Judd: Luke, it will be -- that will be the number for Q4. So the actions were actually taken. I'm not going to remember exactly when, but call it mid-August. So it wasn't kind of done at the end of the quarter. We should see kind of the full impact of that. In terms of cash, right, so there's a $0.3 million charge that hits during Q3 in terms of cash out the door, about 1/3 of that was paid out before the end of the third quarter with the remainder being paid in the fourth quarter. So P&L-wise, the full impact and cash-wise, you'll see some of that trailing into the fourth quarter.

Luke Fingerson: Got it. And then on the MRC, it continues to drive most of the legacy online weakness. Are you seeing any evidence that the rate of decline is moderating?

Dayton Judd: Yes, kind of, but not really. Let me maybe qualify that with some numbers. So we've been seeing kind of strong double-digit declines, about 20% year-over-year for about somewhere between a little bit more than 1.5 years now. The decline started in February of last year, not at the double-digit rates and then accelerated. I mean in recent -- the last 3 quarters or so, it's still declining. But I would say if you look at the sequential rates, perhaps not as bad. I mean just to put a finer point on it, in Q1, MRC online revenue was about $5.1 million. In Q2, it was about $4.9 million. In Q3, it was about $4.5.

So the other thing that's happening is Prime Day, right? So Dr. Tobias and the other MRC brands are primarily Amazon-based brands. Prime Day was in Q2 this year instead of Q3, which was last year. So some sales that would have been in Q3 may be pulled into Q2. So kind of seeing so far sequentially about $0.5 million decline so far year-to-date. So I guess some moderation, but still declining, answers your question.

Operator: Your next question is coming from Sean McGowan with ROTH Capital.

Sean McGowan: Is that a promotion for Ryan?

Dayton Judd: Yes, Ryan Hansen is the President. So I think we announced that earlier this year. I believe it was in May.

Sean McGowan: Okay. So I missed that, but belated congratulations. Following up on the previous questions, can you help us with where on the income statement we would see the benefit of those restructuring savings? Is it all in G&A?

Dayton Judd: It's all in G&A. I referenced kind of in the opening, there's -- we've done more than that, right? So that $1.2 million represents personnel-related savings. There's other things that we have done. We kind of renegotiated our lease or renewed our lease is a better way to say that in Los Angeles, where the Irwin office is based at, I would just say, very substantial savings. We didn't need as much space. So the space we have is a lot smaller and the rate is substantially lower. So we'll save like 50% on our occupancy in L.A., right? You kind of work that out. It's in the 6 figures over the course of the year.

There's other initiatives we've done on both the SG&A front and the cost of goods front. But yes, the only one we kind of quantified, the $1.2 million was all personnel related, and that's all flowing through SG&A.

Sean McGowan: Okay. And then given that last year you had that step-up account or I should say, keeping in mind that last year you had the step-up accounting issue. Can you talk about some of the components of gross margin trend? I would have thought you'd be getting a bit more benefit by now from the shift to online.

Dayton Judd: Yes. So online is still higher margin. The one difference for Irwin, and I think I may have talked about this on a previous call, but I -- if not, I'm happy to kind of address it right now. There's 2 reasons why Irwin's online margins are not as high as the rest of the business. One is Irwin has -- a lot of Irwin's products are lower dollar price. And we include the Amazon referral fee, which is 15% in our cost of goods. And we also include the Amazon FBA, Fulfillment by Amazon shipping charge in our cost of goods.

And when you have a lower dollar price item, the Fulfillment by Amazon as a percent of the revenue tends to be higher. So that's one reason our margins won't be as high as the rest of the business. If you look at Legacy FitLife, the margins there, you can see they're quite a bit higher. And that's one of the reasons why. Another challenge that we have with margins is that most of the Irwin products are in glass bottles. And you can't sell glass bottles on Amazon unless each bottle is wrapped in bubble wrap. And then you've got to do labeling or stickering on the outside of the bubble wrap so they can scan it.

So right now, right, our volumes keep going up significantly on Amazon. But for every single item that we ship into Amazon that's in the glass bottle, our 3PLs have to open the box, take each bottle out, wrap it in bubble wrap, sticker it, put it in a different box because they're now bigger and they can't fit in the same box and then ship it into Amazon. We're probably paying more than $1 a unit right now just on Amazon prep. So one way we can address that is we're not going to abandon glass bottles.

There's some -- the value in that in particularly the health food channel, which is where we also sell a lot of product. But for certain high-volume SKUs, we're going to start packing them out in both glass for the brick-and-mortar channel, but then plastic for the Amazon channel. I think our first SKUs with that pack-out will be probably late this year, early next year. And then we'll start saving kind of $1 a unit, and we'll start to see kind of higher margins on the online side for Irwin as well.

Another thing we're doing, and you can go look at our listings and see this is, if one kind of a single product is $19.99 on Amazon, we'll create a 2-pack version, right, where we're actually packaging 2 bottles together. And instead of charging $40, maybe we'll charge $37 or $36 or something like that, but we pick up quite a bit of savings on the FBA front. So to ship 1 bottle, Amazon might charge us $3.50, but to ship 2 bottles packaged together, they charge us $3.80 total or something like that. So that's another way we can -- we're doing -- making some changes to try and improve our online margins.

To be clear, though, we -- online is still more profitable than brick-and-mortar or than wholesale, I should say. But the margins aren't as attractive as the rest of our business until we kind of make some of these changes.

Sean McGowan: So if we look then at the Legacy business, are you seeing the level of margin improvement that you would expect to get given the shift in -- actually, that online business was down, wasn't it?

Dayton Judd: Yes. So online is declining -- well, largely primarily driven by MRC. But you can see kind of gross margins in that business are fairly consistent.

Sean McGowan: Yes. Okay. One more question, and I'll jump back in the queue. Is Irwin's shift to online, is there evidence -- any evidence that, that might be hurting the wholesale business?

Dayton Judd: So there's no evidence that we can quantify. But unequivocally, right, I don't think we can argue that it isn't. So there are declines in wholesale. We see that more in the health food channel. So I commented in the press release as well as in the introduction to the call today. Specialty retail, just as a channel, and by specialty retail, I mean kind of small box specialty retail, not large grocery stores or Walmart or anything like that, but the smaller mom-and-pop type stores are really challenged in the current environment. You all know we sell a lot through GNC and in particular, the GNC franchise network, and we've kind of talked about the declines we're seeing there.

We're seeing similar declines in the HFS side of Irwin, but not so much in the mass market side. So are some of those people that are -- now that more of our products are available on Amazon and there's a lot more sales happening on Amazon, are some of those people migrating from the brick-and-mortar stores? Absolutely, right? I don't think we can argue at all that they're not. But how much of that -- what the impact is of that, we can't quantify, right? We don't know who it was that was buying in the HFS channel, and we don't know who it is that's buying in the Amazon channel.

But certainly, some people are choosing to buy online.

Operator: [Operator Instructions] The next question comes from Igor Novgorodtsev with Lares Capital.

Igor Novgorodtsev: Dayton, it's nice to be again a shareholder of FitLife after a long track. So I have a few questions. Legacy GNC, specifically the stores, what's the situation there? Is it still representing a significant amount of your sales? And is the decline the result of diminishing store count of GNC franchisees? Or are they just buying less or some combination of the 2?

Dayton Judd: Yes. So first of all, welcome back to being a shareholder. It is a combination of the 2. So it's probably not my business to kind of give their numbers, but there's been a double-digit decline in the number of doors, and I'm talking here specifically franchise locations. So it's a -- when the stores close, right, we lose all of those sales. Maybe some of it transfers to other stores that are close by. But then even in remaining stores, we are seeing in our numbers, meaningful same-store declines. So you add those 2 up, it's kind of -- it's a 20% plus decline.

In terms of the impact on the business overall, GNC at this point is probably close to -- I'm going to guess, I don't have the numbers in front of me, but maybe about $10 million of our revenue, so they are maybe about a 10% customer. There are some things we're doing to address that. We have a handful of brands that have historically been exclusive to GNC. They're going to largely remain exclusive to GNC, but in the face of declines, there's some things that we can do both internationally as well as maybe in independent or in geographic markets where there is no large presence of GNC franchisees.

So we can start to take those brands to stores, locations that don't compete with GNC. So hopefully, that kind of frames the current situation, but call it about $10 million of revenue on an LTM basis, and it's been declining, again, double digits. I don't have the exact number in front of me, but depending on the quarter, maybe 15% to 25%.

Igor Novgorodtsev: Okay. The other question I have is Amazon changed the algorithm, which I believe I discussed with you previously quite in detail. And I understand that you have a team behind your Amazon presence. How much progress have you made so far to address the issues of the changed algorithm, which wasn't favorable to you? And how much is left to do? And kind of where are you at, at this point?

Dayton Judd: Yes. So Amazon is an always changing black box is maybe one way to describe it. I think that we're seeing good momentum on most of the brands, except the MRC brands. And again, I gave some numbers earlier in the call that perhaps shows a reduction in the decline of the MRC brands. I commented in the prepared remarks, like not all of our brands are declining, and our online revenue is growing sequentially. I think Q3 was a very small downtick compared to Q2.

But when you take into account, again, Prime Day shifting from Q3 into Q2 and you kind of normalize for that, right, even though MRC is declining, right, the other brands are growing enough to offset that, right, and then some. So we're seeing some progress. What I've commented before is we see a very strong correlation, very, very high correlation between the percent sales that a brand is getting on Amazon and its performance on Amazon. And that's somewhat counterintuitive. But the more beholden we are or the brand is to Amazon, the less off Amazon presence it has, the worse it does.

And that's kind of MRC definitionally, right, something like 99% of our revenue historically, again, came from Amazon. So are we selling more off Amazon? A bit. We've shifted quite a lot of the advertising dollars for the MRC brands off of Amazon and more kind of DTC. So I think Google, Meta. We've been doing a lot on TikTok. So we've shifted the advertising dollars to try and build awareness off Amazon. But looking at some of the other brands, I commented MusclePharm is -- every month for the past couple of few months has been a new all-time high for MusclePharm.

So when the brand has had stronger off Amazon presence and awareness, it is doing better on Amazon. So our Amazon declines are really an MRC issue. And then we have one other brand or -- it's really not a brand, it's a product that had a really big run last year that -- and it's not doing as well this year, right? So it's a product that got really hot and now is falling somewhat out of favor at least compared to last year. So if I take those out, like everything else is fine.

So that -- so in terms of your specific question, how are we doing with the algorithm changes, I think we're doing pretty well with Dr. Tobias and MRC in particular, the place where we're still seeing the biggest declines, but perhaps not as significant as they have been.

Igor Novgorodtsev: Okay. My other question, which you alluded to is the ingredients and other costs basically going into your gross margin. Have they spiked mostly because of the situation with diesel and oil? Or this is just an ongoing situation, which is specific to other things? In other words, would you think that if the prices of oil come down for one reason or another or diesel, your prices will significantly come down? Or it's really ingredient by ingredient and those are specific problems to your ingredients?

Dayton Judd: Yes. So there's 2 ingredients that have been a challenge. And when I say been a challenge, I actually feel like we've been on top of it. And because of the purchases we've been making over the last, gosh, I think we started forward buying protein last year. You actually -- we don't expect to see these in our cost of goods, right, because we've been -- we're expending the cash sooner to lock in the lower prices. I don't think it really has anything to do with the cost of oil.

I would say the bigger issue with the cost of oil is gas prices being high is affecting the consumer along with a whole lot of other things affecting the consumer, and that's affecting kind of where they spend their money and how they spend their money. The issues with these 2 ingredients, so whey protein is just -- protein has become more and more popular, partially driven by the GLP-1 trends that have been going on and doctors tell people as they lose weight, as they take the GLP-1, they need to supplement with protein.

You see it any time you walk into the convenience store or a grocery store, right, protein's in everything now from candy bars to -- it's in your Starbucks coffee, it's in your potato chips, right? People are putting protein in everything. The net result of that is whey, which has been our primary protein that we have used has gone from about $2.50 a pound a couple of years ago to it peaked around $15 a pound. It's now back down to between $9 and $10. So what we did is we started forward buying the whey last year. We bought a bunch at about $5 a pound, and we bought a bunch at $7.17 a pound.

And that is -- and we're about to finish using that up. So because of that, right, our margins have not been affected perhaps maybe as much as other people have. The other thing is we have not had to be as aggressive in raising our prices. We have raised price, but certainly not as much as a lot of other people. And that, I think, is one big reason why the MusclePharm brand is doing well right now, right? I think we're stealing share because we have a bit of a cost advantage because we locked in the pricing. So we're about to finish production with the last of our whey that we bought at $7.17.

If we were to buy right now in the spot market, it's between $9 and $10. So we'll probably -- once we start dipping into the $9 and $10 whey or buying on the spot market, our costs will go up a bit, and we'll probably raise price again. The other big area, though, and this is a new one is fish oil. And I'm not a fisherman. I can't explain all of the details, but there are fishing seasons when -- and this is a global phenomenon. This has nothing to do with the U.S. In fact, most of the fish oil that is consumed in the U.S. comes from outside the U.S.

There's fishing seasons down around South America, Peru, in particular, and when the catch is not strong or the fish are too small, they have to throw them back and Peru actually, I think, canceled the last fishing season. What I would encourage you all to do is just go to Google, go to AI and just ask what's going on with the fish oil market, and it will explain it to you better than I can. To kind of give very specific numbers, in the third quarter, we paid $1.4 million was the final payment we made for the protein that we had locked in.

And again, that will be consumed over the next couple of months probably or sold in the next couple of few months and converted to cash. On the fish oil side, most of that is still in prepaid, but we made a payment of a few hundred thousand. I can't remember the exact number in Q3 and then another payment very early in Q4. And both of those payments combined, again, I'm going to guess it's $600,000 to $800,000. With that, we've kind of locked in our cost on fish oil for what we think probably until Q4 of '27. So it's a cash outflow now.

But when it flows through the P&L over the next year, right, it will be a favorable cost. We hope to be able to perhaps gain some share on the fish oil side as well like we're seeing in MusclePharm. So long answer, but hopefully, that addressed your question.

Igor Novgorodtsev: Okay. No, no, no, this is very detailed. And I'll just take privilege to ask the last question. So you alluded that certain categories are doing better and certain categories are doing worse, and it has to do basically with consumer being squeezed by higher prices. So which categories are doing better, which ones are doing worse?

Dayton Judd: Yes. I think the way I would say it is everything is doing worse than it was a year ago, is probably the way I would say it. So like again, MusclePharm is doing great right now. But the consumer headwinds that -- look, we've been pretty open. And when we see something, we talk about it. I think it was the third quarter call last year when we first started talking about seeing these kind of consumer headwinds and you kind of see it in the numbers. So where our biggest challenges are, like if I -- there's 2 areas -- 2 problems, right? And we've talked about this, I think, somewhat extensively. Number one is MRC on Amazon.

And number two is the specialty retail channel, right? And so that includes GNC and that includes health food stores for the Irwin brands. If you ignore those, and we can't completely ignore them and pretend they're not there. But if you isolate those from the rest of the business, I don't really see anything in the rest of the business where I am concerned, right? It's generally flat, maybe down a little bit or up a little bit or growing. And so -- in fact, I commented in our remarks, if you take it the last 4 quarters, right, the business is relatively stable, right?

Revenue has been within about $1 million or a little bit more than $1 million, right, in each quarter over the last 4 quarters, right? EBITDA has been within a couple of hundred -- between $3.3 million and $3.7 million. So these challenges, whether it's GNC or the health food stores for Irwin or MRC, right, are being offset by strength in other areas. So I guess I want to make it clear to people like this is not the sky is falling and everything is going down, right? We're dealing with MRC issues, and we're dealing with specialty retail issues, that channel, which, by the way, I don't think is specific to our brands.

GNC is not -- it's not like our brands are down at GNC and everyone else is killing it, right? Or our brands are struggling in HFS and everyone else is killing it, particularly in the smaller independent HFS stores. So hopefully, that answers your question, but those are -- GNC, specialty retail are our problem areas. Everything else, I'm not losing any sleep over.

Operator: We have a follow-up question coming from Sean McGowan with ROTH Capital.

Sean McGowan: You addressed a couple of the other follow-ups I had, but I do have a couple left. Can you be more specific about how the margins at MusclePharm are trending? I think that going back a year or so ago, that was an issue and it sounds like things are going better on the revenue side. Can you talk a little bit more about the margins there?

Dayton Judd: Sure. So -- and back when we used to break out the numbers for MusclePharm, we used to generate, call it, 30% margins. And then we -- when we -- shortly after we bought the brand and we had built some inventory, we wanted to grow the brand. And so we said, hey, we're going to be promotional. We're going to try and build distribution, et cetera, et cetera. And margins went from like 30% down to like 20%. And then I think 1 quarter, maybe even 2 quarters, a little bit below 20%. Then we had the spike in protein prices.

And we basically told there's a number of protein companies that sell protein internationally that are very price aggressive and really just -- I'd call them bottom feeders, but that maybe makes it sound bad, right? It's just their business model. When prices of protein went up, we're just like, sorry, we're not going to sell to you guys anymore, right? Or certainly not at those prices. So part of what we've seen is a shift away from the low-margin international business. And look, we have raised prices wholesale to everyone. So some of those people may continue to buy, but certainly not in the volumes that they used to buy before.

So no, margins are several hundred basis points higher than they were when we last broke them out, which was when they were around, call it, 20-ish percent. So we're not up to 30% yet, but we're north of 25%. I'll just kind of maybe leave it at that. So -- and again, I think we're helped by the fact that we locked in our protein prices. Again we have raised our price both at wholesale and at retail, but not to the extent that other people have. So we've benefited from our forward purchasing there.

Sean McGowan: And then finally, this is more generally speaking, we're now slightly more than halfway through the fourth quarter. You commented a little bit on some things continuing. But more generally, do you think that all the trends that you've seen in the third quarter continued into the fourth?

Dayton Judd: Yes. So online continues to be very strong. MusclePharm October revenue, I think, is probably quite a bit higher. I'll look at it here online while we're talking quite a bit higher than it was, I believe, in September. Yes, I would say, generally, the trends have continued. Revenue -- if I look at shipments, revenue for October is roughly similar to what we've seen throughout the year. We see fluctuations primarily on the wholesale side. We had a lot of product that was in transit at the end of October that will show up in November revenue, but the basic trends are the same. So nothing new to report in that regard.

But here, I'll tell you like some MusclePharm online, at least directionally. Yes, I mean, like October revenue was probably several percent -- let's see, yes, call it 10 -- October revenue for MusclePharm Online was 10% higher than September revenue. Now we also had fall Prime Days or they don't call it Prime Day, but their October Prime essentially for Amazon happens in October. So October is generally a strong month for online across all of the brands, not just MusclePharm.

Sean McGowan: Okay. And MRC is still trending as it was?

Dayton Judd: Yes. MRC, nothing different than the kind of previous trends that I called out. I will say, again, I don't know -- I don't have a number for Q4. I'm not giving guidance. I'd just remind everyone, Q4 is generally the weakest quarter just seasonally in the supplement business and then Q1 and Q2 are generally stronger. We didn't unfortunately experience that earlier this year, the Q1 and Q2 part, but we're hoping that things get -- that pattern resumes starting next year.

Operator: Okay. We currently have no further questions in the queue. This concludes the Q&A portion of the call. I'd like to turn the floor back to management for any closing remarks.

Dayton Judd: Well, thank you all for participating in the call. If you have any other questions, either now or in the coming months, please feel free to reach out. And we look forward to talking to you on our next call. Thank you.

Operator: This concludes today's conference, and you may disconnect your lines at this time. Thank you for your participation.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool recommends FitLife Brands. The Motley Fool has a disclosure policy.